192 related articles for article (PubMed ID: 21219234)
1. Current advances in cell therapy strategies for muscular dystrophies.
Negroni E; Vallese D; Vilquin JT; Butler-Browne G; Mouly V; Trollet C
Expert Opin Biol Ther; 2011 Feb; 11(2):157-76. PubMed ID: 21219234
[TBL] [Abstract][Full Text] [Related]
2. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
3. Cell therapy strategies and improvements for muscular dystrophy.
Quattrocelli M; Cassano M; Crippa S; Perini I; Sampaolesi M
Cell Death Differ; 2010 Aug; 17(8):1222-9. PubMed ID: 19876070
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic strategy for muscular dystrophies].
Shin JH; Takeda S
Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for muscular dystrophy: current progress and future prospects.
Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
[TBL] [Abstract][Full Text] [Related]
6. Myoblast transfer therapy: is there any light at the end of the tunnel?
Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
[TBL] [Abstract][Full Text] [Related]
7. [Molecular therapy of muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
[TBL] [Abstract][Full Text] [Related]
8. Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.
Negroni E; Gidaro T; Bigot A; Butler-Browne GS; Mouly V; Trollet C
Neuropathol Appl Neurobiol; 2015 Apr; 41(3):270-87. PubMed ID: 25405809
[TBL] [Abstract][Full Text] [Related]
9. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.
Salani S; Donadoni C; Rizzo F; Bresolin N; Comi GP; Corti S
J Cell Mol Med; 2012 Jul; 16(7):1353-64. PubMed ID: 22129481
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets to treat muscular dystrophies.
Kinter J; Sinnreich M
Swiss Med Wkly; 2014 Feb; 144():w13916. PubMed ID: 24554202
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of stem cell therapy in Duchenne muscular dystrophy.
Meregalli M; Farini A; Belicchi M; Parolini D; Cassinelli L; Razini P; Sitzia C; Torrente Y
FEBS J; 2013 Sep; 280(17):4251-62. PubMed ID: 23206279
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
[TBL] [Abstract][Full Text] [Related]
13. Systemic cell therapy for muscular dystrophies : The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy.
Ausems CRM; van Engelen BGM; van Bokhoven H; Wansink DG
Stem Cell Rev Rep; 2021 Jun; 17(3):878-899. PubMed ID: 33349909
[TBL] [Abstract][Full Text] [Related]
14. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
Nishiyama T; Takeda S
Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
[TBL] [Abstract][Full Text] [Related]
15. Stem cell based therapies to treat muscular dystrophy.
Price FD; Kuroda K; Rudnicki MA
Biochim Biophys Acta; 2007 Feb; 1772(2):272-83. PubMed ID: 17034994
[TBL] [Abstract][Full Text] [Related]
16. Muscular dystrophies: histology, immunohistochemistry, molecular genetics and management.
Costanza L; Moggio M
Curr Pharm Des; 2010; 16(8):978-87. PubMed ID: 20041828
[TBL] [Abstract][Full Text] [Related]
17. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
Stedman HH
Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
[TBL] [Abstract][Full Text] [Related]
18. Myogenic stem cells: regeneration and cell therapy in human skeletal muscle.
Negroni E; Butler-Browne GS; Mouly V
Pathol Biol (Paris); 2006 Mar; 54(2):100-8. PubMed ID: 16246502
[TBL] [Abstract][Full Text] [Related]
19. Emerging strategies for cell and gene therapy of the muscular dystrophies.
Muir LA; Chamberlain JS
Expert Rev Mol Med; 2009 Jun; 11():e18. PubMed ID: 19555515
[TBL] [Abstract][Full Text] [Related]
20. The new frontier in muscular dystrophy research: booster genes.
Engvall E; Wewer UM
FASEB J; 2003 Sep; 17(12):1579-84. PubMed ID: 12958164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
